29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Over the course of a long driving history, usually 50 to 60 years, an average driver is likely to be...
Read More >
The Nevada Legislature’s 80th session recently came to a close after a flurry of activity resulted ...
Read More >
If you own a successful privately held business, then it is likely you have received a call from a p...
Read More >
Dividend recapitalization activity plunged in the immediate aftermath of COVID-19 but, as markets re...
Read More >
On August 20, 2019, the United States Court of Appeals for the Ninth Circuit overturned its long-sta...
Read More >
The Maryland legislature passed new legislation and revised other legislation throughout 2019. Below...
Read More >